tiprankstipranks
Advertisement
Advertisement
Jazz Pharmaceuticals price target raised to $239 from $227 at Raymond James
PremiumThe FlyJazz Pharmaceuticals price target raised to $239 from $227 at Raymond James
12d ago
Jazz Pharmaceuticals Signals Confidence After Record Quarter
Premium
Company Announcements
Jazz Pharmaceuticals Signals Confidence After Record Quarter
12d ago
Jazz Pharmaceuticals reports Q1 adjusted EPS $6.34, consensus $4.66
Premium
The Fly
Jazz Pharmaceuticals reports Q1 adjusted EPS $6.34, consensus $4.66
13d ago
Nike downgraded, IBM initiated: Wall Street’s top analyst calls
PremiumThe FlyNike downgraded, IBM initiated: Wall Street’s top analyst calls
1M ago
Jazz Pharmaceuticals resumed with an Outperform at Raymond James
Premium
The Fly
Jazz Pharmaceuticals resumed with an Outperform at Raymond James
1M ago
Jazz Pharmaceuticals price target raised to $232 from $219 at Piper Sandler
Premium
The Fly
Jazz Pharmaceuticals price target raised to $232 from $219 at Piper Sandler
2M ago
Jazz Pharmaceuticals Balances Record Gains With Slower 2026
PremiumCompany AnnouncementsJazz Pharmaceuticals Balances Record Gains With Slower 2026
3M ago
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
Premium
The Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
3M ago
Jazz Pharmaceuticals Advances ONC206 Trial in Rare Tumors, Offering a New Pipeline Catalyst for JAZZ
Premium
Company Announcements
Jazz Pharmaceuticals Advances ONC206 Trial in Rare Tumors, Offering a New Pipeline Catalyst for JAZZ
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100